(3beta,5beta)-3-[(2,6-Dideoxy-3-O-methyl-beta-D-lyxo-hexopyranosyl)oxy]-14-hydroxycard-20(22)-enolide(CAS: 12738-19-1)

The compound is subject to GHS classification and requires SDS preparation. REACH regulations mandate registration for manufacturers and importers. FDA and EPA have specific requirements for handling and disposal due to its potential biological activity and environmental impact.

Alternative reagents such as 3-[(2,6-Dideoxy-3-O-methyl-beta-D-lyxo-hexopyranosyl)oxy]-14-hydroxycard-20(22)-enolide and related isomers can be used as substitutes. Common synthesis methods include chemical modification and biosynthesis using microbial fermentation.

There is increasing interest in the compound for its potential medicinal applications. Research trends focus on its pharmacological properties and development of derivatives. Market trends show a growing demand in pharmaceutical and natural product industries.

Waste should be collected in properly labeled containers and disposed of through professional waste disposal services. Incineration or safe landfilling methods are preferred. Environmental protection measures include minimizing spillage and ensuring compliance with local hazardous waste regulations.